Jazz Pharmaceuticals PLC
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +30.2% | -3.3% | -43.4% | -8.6% | +26.4% | +86.8% | +675.5% | +13.8% | +49.2% | +0.6% | +42.9% | +6.7% | +1.6% | +6.4% | +18.0% | +88.2% | -11.9% | +5.2% | +5.4% | -2.9% | |
| – | – | +191.8% | +26.8% | -62.1% | -16.0% | +101.5% | +167.4% | +177.0% | +56.8% | +17.5% | +23.8% | -40.5% | +29.4% | +27.4% | +32.1% | +74.2% | -8.0% | -0.2% | +31.8% | +34.7% | -10.0% | |
| – | – | +283.0% | +30.4% | -75.8% | -37.4% | +187.2% | +83.2% | +371.8% | +64.4% | +7.5% | +44.6% | -63.0% | +5.5% | -19.8% | +105.8% | +66.0% | -44.1% | +49.0% | +70.9% | +60.2% | -42.3% | |
| – | – | +283.0% | +30.4% | -74.8% | -39.8% | +187.2% | +252.5% | +145.2% | +64.4% | +7.5% | +44.6% | -56.9% | +41.1% | +37.2% | +30.6% | +98.0% | -72.3% | +49.0% | +84.5% | +84.0% | -18.4% | |
| – | – | +49.6% | +0.2% | +23.3% | +85.4% | +79.3% | +55.7% | +119.6% | +65.3% | +49.3% | +12.5% | +11.7% | -4.3% | +17.7% | +34.9% | +11.4% | +42.1% | +15.6% | +8.3% | +1.6% | +15.9% | |
| – | – | -7.2% | -26.9% | +116.4% | -28.4% | +47.3% | -22.5% | +578.6% | +8.1% | +4.8% | -35.2% | +75.1% | +27.0% | +22.5% | +48.4% | +21.4% | +1,024.5% | -33.4% | -16.4% | -19.5% | -13.2% | |
| – | – | +8.6% | +87.0% | -36.2% | -55.3% | -38.6% | +125.7% | +367.6% | +95.7% | +309.7% | +46.6% | +25.6% | +58.2% | +17.8% | +35.2% | -52.8% | +168.4% | -12.2% | – | – | – | |
| – | – | -1.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +1,058.2% | +1.8% | +56.0% | -6.5% | +36.0% | +6.0% | -2.1% | -0.8% | +4.2% | +90.7% | -7.4% | +3.6% | -2.1% | +6.6% | |
| – | – | -12.2% | -47.9% | -9.8% | -8.2% | -26.2% | -33.8% | +5,864.7% | -6.6% | +76.9% | -17.5% | +154.0% | -1.1% | -8.3% | -10.6% | -10.1% | +225.8% | -19.0% | -6.5% | -12.2% | -6.9% | |
| – | – | +38.1% | -61.0% | +37.9% | -14.3% | -41.6% | -42.2% | +1,290.5% | +11.5% | +108.7% | -10.5% | +66.0% | -17.5% | +1.5% | -0.7% | +18.5% | +189.7% | -7.0% | -1.2% | +3.4% | -7.3% | |
| – | – | +30.8% | +20.8% | +370.7% | -65.9% | +1.2% | -11.8% | +262.3% | +6.5% | +6.3% | +4.5% | +13.6% | +14.2% | +17.5% | +5.5% | +79.4% | +23.8% | +15.3% | +64.7% | -32.4% | +115.9% | |
| – | – | – | +57.9% | +3,438.9% | -72.9% | -29.4% | +67.8% | -24.4% | -81.2% | +69.2% | +298.7% | -4.0% | +12.5% | -17.8% | +38.1% | +465.5% | -82.1% | +0.4% | +1,230.3% | -92.7% | +2,181.9% | |
| – | – | +13.7% | -47.5% | +100.8% | -62.4% | +41.3% | +68.2% | +209.7% | +32.2% | +19.6% | -13.2% | +2.8% | +8.7% | +66.6% | +17.1% | -43.3% | +272.2% | -9.5% | +13.2% | -24.2% | +56.8% | |
| – | – | -16.6% | +1.1% | – | – | -73.0% | -100.0% | – | +27.5% | +144.9% | -12.5% | +70.8% | -22.7% | +1.5% | +0.7% | +17.5% | +225.6% | -5.4% | -10.3% | +19.0% | -28.8% | |
| – | – | – | – | -268.9% | – | – | +531.0% | +481.6% | +15.5% | +5.8% | +16.6% | +17.4% | +44.5% | +1.6% | +12.8% | +17.6% | +8.3% | -22.2% | +21.1% | +9.5% | +5.5% | |
| – | – | – | – | – | – | – | – | – | – | +87.3% | +772.2% | +74.7% | +73.6% | -8.4% | +27.0% | +8.6% | -28.4% | -11.6% | +19.8% | +28.3% | -42.7% | |
| – | +0.0% | +0.0% | +2.7% | +85.5% | +17.0% | +31.3% | +18.7% | +28.6% | +2.3% | +1.7% | +0.7% | -1.8% | -0.9% | -0.2% | -6.0% | -1.8% | +5.6% | +4.8% | +15.2% | -8.4% | -7.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.